Drug-Coated Balloons-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Drug-Coated Balloons-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Drug-Coated Balloons industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Drug-Coated Balloons 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Drug-Coated Balloons worldwide and market share by regions, with company and product introduction, position in the Drug-Coated Balloons market
Market status and development trend of Drug-Coated Balloons by types and applications
Cost and profit status of Drug-Coated Balloons, and marketing status
Market growth drivers and challenges
The report segments the global Drug-Coated Balloons market as:
Global Drug-Coated Balloons Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Drug-Coated Balloons Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Semi-Compliant Balloons
Non-Compliant Balloons
Global Drug-Coated Balloons Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Clinics
Ambulatory Surgical Centers
Other
Global Drug-Coated Balloons Market: Manufacturers Segment Analysis (Company and Product introduction, Drug-Coated Balloons Sales Volume, Revenue, Price and Gross Margin):
Natec Medical
Cook Medical
Medtronic
C.R. Bard
Boston Scientific
Spectranetics Corporation
Endocor GmbH
Biotronik
Cordis Corporation
Abbott Laboratories
Smiths Medical
Opto Circuits
Asahi Intecc
Angioslide
Tokai Medical
Atrium Medical
Lepu Medical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Drug-Coated Balloons-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Drug-Coated Balloons industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Drug-Coated Balloons 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Drug-Coated Balloons worldwide and market share by regions, with company and product introduction, position in the Drug-Coated Balloons market
Market status and development trend of Drug-Coated Balloons by types and applications
Cost and profit status of Drug-Coated Balloons, and marketing status
Market growth drivers and challenges
The report segments the global Drug-Coated Balloons market as:
Global Drug-Coated Balloons Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Drug-Coated Balloons Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Semi-Compliant Balloons
Non-Compliant Balloons
Global Drug-Coated Balloons Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Clinics
Ambulatory Surgical Centers
Other
Global Drug-Coated Balloons Market: Manufacturers Segment Analysis (Company and Product introduction, Drug-Coated Balloons Sales Volume, Revenue, Price and Gross Margin):
Natec Medical
Cook Medical
Medtronic
C.R. Bard
Boston Scientific
Spectranetics Corporation
Endocor GmbH
Biotronik
Cordis Corporation
Abbott Laboratories
Smiths Medical
Opto Circuits
Asahi Intecc
Angioslide
Tokai Medical
Atrium Medical
Lepu Medical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF DRUG-COATED BALLOONS
1.1 Definition of Drug-Coated Balloons in This Report
1.2 Commercial Types of Drug-Coated Balloons
1.2.1 Semi-Compliant Balloons
1.2.2 Non-Compliant Balloons
1.3 Downstream Application of Drug-Coated Balloons
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Ambulatory Surgical Centers
1.3.4 Other
1.4 Development History of Drug-Coated Balloons
1.5 Market Status and Trend of Drug-Coated Balloons 2013-2023
1.5.1 Global Drug-Coated Balloons Market Status and Trend 2013-2023
1.5.2 Regional Drug-Coated Balloons Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Drug-Coated Balloons 2013-2017
2.2 Sales Market of Drug-Coated Balloons by Regions
2.2.1 Sales Volume of Drug-Coated Balloons by Regions
2.2.2 Sales Value of Drug-Coated Balloons by Regions
2.3 Production Market of Drug-Coated Balloons by Regions
2.4 Global Market Forecast of Drug-Coated Balloons 2018-2023
2.4.1 Global Market Forecast of Drug-Coated Balloons 2018-2023
2.4.2 Market Forecast of Drug-Coated Balloons by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Drug-Coated Balloons by Types
3.2 Sales Value of Drug-Coated Balloons by Types
3.3 Market Forecast of Drug-Coated Balloons by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Drug-Coated Balloons by Downstream Industry
4.2 Global Market Forecast of Drug-Coated Balloons by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Drug-Coated Balloons Market Status by Countries
5.1.1 North America Drug-Coated Balloons Sales by Countries (2013-2017)
5.1.2 North America Drug-Coated Balloons Revenue by Countries (2013-2017)
5.1.3 United States Drug-Coated Balloons Market Status (2013-2017)
5.1.4 Canada Drug-Coated Balloons Market Status (2013-2017)
5.1.5 Mexico Drug-Coated Balloons Market Status (2013-2017)
5.2 North America Drug-Coated Balloons Market Status by Manufacturers
5.3 North America Drug-Coated Balloons Market Status by Type (2013-2017)
5.3.1 North America Drug-Coated Balloons Sales by Type (2013-2017)
5.3.2 North America Drug-Coated Balloons Revenue by Type (2013-2017)
5.4 North America Drug-Coated Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Drug-Coated Balloons Market Status by Countries
6.1.1 Europe Drug-Coated Balloons Sales by Countries (2013-2017)
6.1.2 Europe Drug-Coated Balloons Revenue by Countries (2013-2017)
6.1.3 Germany Drug-Coated Balloons Market Status (2013-2017)
6.1.4 UK Drug-Coated Balloons Market Status (2013-2017)
6.1.5 France Drug-Coated Balloons Market Status (2013-2017)
6.1.6 Italy Drug-Coated Balloons Market Status (2013-2017)
6.1.7 Russia Drug-Coated Balloons Market Status (2013-2017)
6.1.8 Spain Drug-Coated Balloons Market Status (2013-2017)
6.1.9 Benelux Drug-Coated Balloons Market Status (2013-2017)
6.2 Europe Drug-Coated Balloons Market Status by Manufacturers
6.3 Europe Drug-Coated Balloons Market Status by Type (2013-2017)
6.3.1 Europe Drug-Coated Balloons Sales by Type (2013-2017)
6.3.2 Europe Drug-Coated Balloons Revenue by Type (2013-2017)
6.4 Europe Drug-Coated Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Drug-Coated Balloons Market Status by Countries
7.1.1 Asia Pacific Drug-Coated Balloons Sales by Countries (2013-2017)
7.1.2 Asia Pacific Drug-Coated Balloons Revenue by Countries (2013-2017)
7.1.3 China Drug-Coated Balloons Market Status (2013-2017)
7.1.4 Japan Drug-Coated Balloons Market Status (2013-2017)
7.1.5 India Drug-Coated Balloons Market Status (2013-2017)
7.1.6 Southeast Asia Drug-Coated Balloons Market Status (2013-2017)
7.1.7 Australia Drug-Coated Balloons Market Status (2013-2017)
7.2 Asia Pacific Drug-Coated Balloons Market Status by Manufacturers
7.3 Asia Pacific Drug-Coated Balloons Market Status by Type (2013-2017)
7.3.1 Asia Pacific Drug-Coated Balloons Sales by Type (2013-2017)
7.3.2 Asia Pacific Drug-Coated Balloons Revenue by Type (2013-2017)
7.4 Asia Pacific Drug-Coated Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Drug-Coated Balloons Market Status by Countries
8.1.1 Latin America Drug-Coated Balloons Sales by Countries (2013-2017)
8.1.2 Latin America Drug-Coated Balloons Revenue by Countries (2013-2017)
8.1.3 Brazil Drug-Coated Balloons Market Status (2013-2017)
8.1.4 Argentina Drug-Coated Balloons Market Status (2013-2017)
8.1.5 Colombia Drug-Coated Balloons Market Status (2013-2017)
8.2 Latin America Drug-Coated Balloons Market Status by Manufacturers
8.3 Latin America Drug-Coated Balloons Market Status by Type (2013-2017)
8.3.1 Latin America Drug-Coated Balloons Sales by Type (2013-2017)
8.3.2 Latin America Drug-Coated Balloons Revenue by Type (2013-2017)
8.4 Latin America Drug-Coated Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Drug-Coated Balloons Market Status by Countries
9.1.1 Middle East and Africa Drug-Coated Balloons Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Drug-Coated Balloons Revenue by Countries (2013-2017)
9.1.3 Middle East Drug-Coated Balloons Market Status (2013-2017)
9.1.4 Africa Drug-Coated Balloons Market Status (2013-2017)
9.2 Middle East and Africa Drug-Coated Balloons Market Status by Manufacturers
9.3 Middle East and Africa Drug-Coated Balloons Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Drug-Coated Balloons Sales by Type (2013-2017)
9.3.2 Middle East and Africa Drug-Coated Balloons Revenue by Type (2013-2017)
9.4 Middle East and Africa Drug-Coated Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF DRUG-COATED BALLOONS
10.1 Global Economy Situation and Trend Overview
10.2 Drug-Coated Balloons Downstream Industry Situation and Trend Overview
CHAPTER 11 DRUG-COATED BALLOONS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Drug-Coated Balloons by Major Manufacturers
11.2 Production Value of Drug-Coated Balloons by Major Manufacturers
11.3 Basic Information of Drug-Coated Balloons by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Drug-Coated Balloons Major Manufacturer
11.3.2 Employees and Revenue Level of Drug-Coated Balloons Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 DRUG-COATED BALLOONS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Natec Medical
12.1.1 Company profile
12.1.2 Representative Drug-Coated Balloons Product
12.1.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Natec Medical
12.2 Cook Medical
12.2.1 Company profile
12.2.2 Representative Drug-Coated Balloons Product
12.2.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Cook Medical
12.3 Medtronic
12.3.1 Company profile
12.3.2 Representative Drug-Coated Balloons Product
12.3.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Medtronic
12.4 C.R. Bard
12.4.1 Company profile
12.4.2 Representative Drug-Coated Balloons Product
12.4.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of C.R. Bard
12.5 Boston Scientific
12.5.1 Company profile
12.5.2 Representative Drug-Coated Balloons Product
12.5.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Boston Scientific
12.6 Spectranetics Corporation
12.6.1 Company profile
12.6.2 Representative Drug-Coated Balloons Product
12.6.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Spectranetics Corporation
12.7 Endocor GmbH
12.7.1 Company profile
12.7.2 Representative Drug-Coated Balloons Product
12.7.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Endocor GmbH
12.8 Biotronik
12.8.1 Company profile
12.8.2 Representative Drug-Coated Balloons Product
12.8.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Biotronik
12.9 Cordis Corporation
12.9.1 Company profile
12.9.2 Representative Drug-Coated Balloons Product
12.9.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Cordis Corporation
12.10 Abbott Laboratories
12.10.1 Company profile
12.10.2 Representative Drug-Coated Balloons Product
12.10.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Abbott Laboratories
12.11 Smiths Medical
12.11.1 Company profile
12.11.2 Representative Drug-Coated Balloons Product
12.11.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Smiths Medical
12.12 Opto Circuits
12.12.1 Company profile
12.12.2 Representative Drug-Coated Balloons Product
12.12.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Opto Circuits
12.13 Asahi Intecc
12.13.1 Company profile
12.13.2 Representative Drug-Coated Balloons Product
12.13.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Asahi Intecc
12.14 Angioslide
12.14.1 Company profile
12.14.2 Representative Drug-Coated Balloons Product
12.14.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Angioslide
12.15 Tokai Medical
12.15.1 Company profile
12.15.2 Representative Drug-Coated Balloons Product
12.15.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Tokai Medical
12.16 Atrium Medical
12.17 Lepu Medical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG-COATED BALLOONS
13.1 Industry Chain of Drug-Coated Balloons
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF DRUG-COATED BALLOONS
14.1 Cost Structure Analysis of Drug-Coated Balloons
14.2 Raw Materials Cost Analysis of Drug-Coated Balloons
14.3 Labor Cost Analysis of Drug-Coated Balloons
14.4 Manufacturing Expenses Analysis of Drug-Coated Balloons
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Drug-Coated Balloons in This Report
1.2 Commercial Types of Drug-Coated Balloons
1.2.1 Semi-Compliant Balloons
1.2.2 Non-Compliant Balloons
1.3 Downstream Application of Drug-Coated Balloons
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Ambulatory Surgical Centers
1.3.4 Other
1.4 Development History of Drug-Coated Balloons
1.5 Market Status and Trend of Drug-Coated Balloons 2013-2023
1.5.1 Global Drug-Coated Balloons Market Status and Trend 2013-2023
1.5.2 Regional Drug-Coated Balloons Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Drug-Coated Balloons 2013-2017
2.2 Sales Market of Drug-Coated Balloons by Regions
2.2.1 Sales Volume of Drug-Coated Balloons by Regions
2.2.2 Sales Value of Drug-Coated Balloons by Regions
2.3 Production Market of Drug-Coated Balloons by Regions
2.4 Global Market Forecast of Drug-Coated Balloons 2018-2023
2.4.1 Global Market Forecast of Drug-Coated Balloons 2018-2023
2.4.2 Market Forecast of Drug-Coated Balloons by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Drug-Coated Balloons by Types
3.2 Sales Value of Drug-Coated Balloons by Types
3.3 Market Forecast of Drug-Coated Balloons by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Drug-Coated Balloons by Downstream Industry
4.2 Global Market Forecast of Drug-Coated Balloons by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Drug-Coated Balloons Market Status by Countries
5.1.1 North America Drug-Coated Balloons Sales by Countries (2013-2017)
5.1.2 North America Drug-Coated Balloons Revenue by Countries (2013-2017)
5.1.3 United States Drug-Coated Balloons Market Status (2013-2017)
5.1.4 Canada Drug-Coated Balloons Market Status (2013-2017)
5.1.5 Mexico Drug-Coated Balloons Market Status (2013-2017)
5.2 North America Drug-Coated Balloons Market Status by Manufacturers
5.3 North America Drug-Coated Balloons Market Status by Type (2013-2017)
5.3.1 North America Drug-Coated Balloons Sales by Type (2013-2017)
5.3.2 North America Drug-Coated Balloons Revenue by Type (2013-2017)
5.4 North America Drug-Coated Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Drug-Coated Balloons Market Status by Countries
6.1.1 Europe Drug-Coated Balloons Sales by Countries (2013-2017)
6.1.2 Europe Drug-Coated Balloons Revenue by Countries (2013-2017)
6.1.3 Germany Drug-Coated Balloons Market Status (2013-2017)
6.1.4 UK Drug-Coated Balloons Market Status (2013-2017)
6.1.5 France Drug-Coated Balloons Market Status (2013-2017)
6.1.6 Italy Drug-Coated Balloons Market Status (2013-2017)
6.1.7 Russia Drug-Coated Balloons Market Status (2013-2017)
6.1.8 Spain Drug-Coated Balloons Market Status (2013-2017)
6.1.9 Benelux Drug-Coated Balloons Market Status (2013-2017)
6.2 Europe Drug-Coated Balloons Market Status by Manufacturers
6.3 Europe Drug-Coated Balloons Market Status by Type (2013-2017)
6.3.1 Europe Drug-Coated Balloons Sales by Type (2013-2017)
6.3.2 Europe Drug-Coated Balloons Revenue by Type (2013-2017)
6.4 Europe Drug-Coated Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Drug-Coated Balloons Market Status by Countries
7.1.1 Asia Pacific Drug-Coated Balloons Sales by Countries (2013-2017)
7.1.2 Asia Pacific Drug-Coated Balloons Revenue by Countries (2013-2017)
7.1.3 China Drug-Coated Balloons Market Status (2013-2017)
7.1.4 Japan Drug-Coated Balloons Market Status (2013-2017)
7.1.5 India Drug-Coated Balloons Market Status (2013-2017)
7.1.6 Southeast Asia Drug-Coated Balloons Market Status (2013-2017)
7.1.7 Australia Drug-Coated Balloons Market Status (2013-2017)
7.2 Asia Pacific Drug-Coated Balloons Market Status by Manufacturers
7.3 Asia Pacific Drug-Coated Balloons Market Status by Type (2013-2017)
7.3.1 Asia Pacific Drug-Coated Balloons Sales by Type (2013-2017)
7.3.2 Asia Pacific Drug-Coated Balloons Revenue by Type (2013-2017)
7.4 Asia Pacific Drug-Coated Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Drug-Coated Balloons Market Status by Countries
8.1.1 Latin America Drug-Coated Balloons Sales by Countries (2013-2017)
8.1.2 Latin America Drug-Coated Balloons Revenue by Countries (2013-2017)
8.1.3 Brazil Drug-Coated Balloons Market Status (2013-2017)
8.1.4 Argentina Drug-Coated Balloons Market Status (2013-2017)
8.1.5 Colombia Drug-Coated Balloons Market Status (2013-2017)
8.2 Latin America Drug-Coated Balloons Market Status by Manufacturers
8.3 Latin America Drug-Coated Balloons Market Status by Type (2013-2017)
8.3.1 Latin America Drug-Coated Balloons Sales by Type (2013-2017)
8.3.2 Latin America Drug-Coated Balloons Revenue by Type (2013-2017)
8.4 Latin America Drug-Coated Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Drug-Coated Balloons Market Status by Countries
9.1.1 Middle East and Africa Drug-Coated Balloons Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Drug-Coated Balloons Revenue by Countries (2013-2017)
9.1.3 Middle East Drug-Coated Balloons Market Status (2013-2017)
9.1.4 Africa Drug-Coated Balloons Market Status (2013-2017)
9.2 Middle East and Africa Drug-Coated Balloons Market Status by Manufacturers
9.3 Middle East and Africa Drug-Coated Balloons Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Drug-Coated Balloons Sales by Type (2013-2017)
9.3.2 Middle East and Africa Drug-Coated Balloons Revenue by Type (2013-2017)
9.4 Middle East and Africa Drug-Coated Balloons Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF DRUG-COATED BALLOONS
10.1 Global Economy Situation and Trend Overview
10.2 Drug-Coated Balloons Downstream Industry Situation and Trend Overview
CHAPTER 11 DRUG-COATED BALLOONS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Drug-Coated Balloons by Major Manufacturers
11.2 Production Value of Drug-Coated Balloons by Major Manufacturers
11.3 Basic Information of Drug-Coated Balloons by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Drug-Coated Balloons Major Manufacturer
11.3.2 Employees and Revenue Level of Drug-Coated Balloons Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 DRUG-COATED BALLOONS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Natec Medical
12.1.1 Company profile
12.1.2 Representative Drug-Coated Balloons Product
12.1.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Natec Medical
12.2 Cook Medical
12.2.1 Company profile
12.2.2 Representative Drug-Coated Balloons Product
12.2.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Cook Medical
12.3 Medtronic
12.3.1 Company profile
12.3.2 Representative Drug-Coated Balloons Product
12.3.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Medtronic
12.4 C.R. Bard
12.4.1 Company profile
12.4.2 Representative Drug-Coated Balloons Product
12.4.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of C.R. Bard
12.5 Boston Scientific
12.5.1 Company profile
12.5.2 Representative Drug-Coated Balloons Product
12.5.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Boston Scientific
12.6 Spectranetics Corporation
12.6.1 Company profile
12.6.2 Representative Drug-Coated Balloons Product
12.6.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Spectranetics Corporation
12.7 Endocor GmbH
12.7.1 Company profile
12.7.2 Representative Drug-Coated Balloons Product
12.7.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Endocor GmbH
12.8 Biotronik
12.8.1 Company profile
12.8.2 Representative Drug-Coated Balloons Product
12.8.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Biotronik
12.9 Cordis Corporation
12.9.1 Company profile
12.9.2 Representative Drug-Coated Balloons Product
12.9.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Cordis Corporation
12.10 Abbott Laboratories
12.10.1 Company profile
12.10.2 Representative Drug-Coated Balloons Product
12.10.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Abbott Laboratories
12.11 Smiths Medical
12.11.1 Company profile
12.11.2 Representative Drug-Coated Balloons Product
12.11.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Smiths Medical
12.12 Opto Circuits
12.12.1 Company profile
12.12.2 Representative Drug-Coated Balloons Product
12.12.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Opto Circuits
12.13 Asahi Intecc
12.13.1 Company profile
12.13.2 Representative Drug-Coated Balloons Product
12.13.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Asahi Intecc
12.14 Angioslide
12.14.1 Company profile
12.14.2 Representative Drug-Coated Balloons Product
12.14.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Angioslide
12.15 Tokai Medical
12.15.1 Company profile
12.15.2 Representative Drug-Coated Balloons Product
12.15.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Tokai Medical
12.16 Atrium Medical
12.17 Lepu Medical
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG-COATED BALLOONS
13.1 Industry Chain of Drug-Coated Balloons
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF DRUG-COATED BALLOONS
14.1 Cost Structure Analysis of Drug-Coated Balloons
14.2 Raw Materials Cost Analysis of Drug-Coated Balloons
14.3 Labor Cost Analysis of Drug-Coated Balloons
14.4 Manufacturing Expenses Analysis of Drug-Coated Balloons
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
